Telegram-
Loading indices

KOSDAQ · 950260

INGENIA Therapeutics(Reg.S)

Market cap₩1.07T
PERN/A
PBR62.65×
Foreign ownership1.06%
Avg. analyst target₩25,000

Pension summary

as of Oct 19
streakNone
5D₩0M
20D+₩400M
60D-₩680M
Foreign 20D+₩3.0B
Inst. 20D+₩1.0B

Pension daily net buy

-

Cumulative net buying by investor

-
선택 기간의 net buy Total · ₩100M
DateClosePension fundsForeignInstitutionsRetail
10/1925,350–-₩1.9B-₩210M+₩2.2B
10/1625,350–-₩3.0B+₩10M+₩2.8B
10/1525,350–+₩1.3B+₩670M-₩2.0B
10/1425,350–-₩480M+₩30M+₩600M
10/1325,350–+₩650M-₩500M+₩140M
10/1225,350–+₩220M-₩110M+₩60M
10/825,350–+₩1.5B-₩3.3B+₩2.8B
10/728,300–-₩30M-₩580M+₩760M
10/629,250–+₩1.0B-₩1.1B+₩380M
10/228,850–-₩1.3B+₩230M+₩3.0B

Discussion

Google-verified members · return since posting
0/300

  1. Loading

ETF

ETFs holding it in their top 10 · recent changes

10/08 이후 큰 ETF 변화는 없어요

All ETF index changes →

Recent filings

DART
  1. Loading

Broker reports

Recent

Recent reports 없어요.

Same sector

  1. Alteogen
  2. ABL Bio
  3. Hugel
  4. PEPTRON
  5. D&D Pharmatech
  6. NATURECELL

INGENIA Therapeutics(Reg.S) summary

INGENIA Therapeutics(Reg.S)(950260). Pension funds last 20 trading days +₩400M. Market cap ₩1.07T, PER N/A, PBR 62.65×. Avg. analyst target ₩25,000. Pension flows are based on Korea Exchange investor statistics, for reference only.